This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

Key PointsBoone Capital added 398,482 shares of TYRA in the fourth quarter.The quarter-end position value rose by $10.48 million as a result of the new stake.The new position, though significant, is not among the fund’s top five holdings.10 stocks we like better than Tyra Biosciences › On February 17, 2026, Boone Capital Management disclosed a new position in Tyra Biosciences (NASDAQ:TYRA), acquiring 398,482 shares worth $10.48 million at quarte…